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Abstract 
Background: In many nations, there has been an increase in the prevalence of allergic diseases, many of which lack 
therapies for recovery. In addition, there are concerns regarding the use of conventional medicine, particularly 
corticosteroids, in children. Accordingly, in the case of asthma, many chronic allergic patients are looking at 
complementary and alternative drugs to treat their condition. 
Objective: The study intended to observe the impact of traditional Chinese medicine (TCM) prescriptions children 
with asthma, with a specific focus on their impact on the molecular mechanism of asthma. 
Method:  A total number of 167 children with symptom of asthma were included in the study and were randomly 
allocated to two groups – those who received traditional Chinese medicine (TCM, the TCM group, n = 90) and those 
who were given salbutamol plus montelukast (SM, the SM group, n = 77). Different TCM treatments were given to 
patients in the TCM group, while salbutamol and montelukast were given to the SM group. The appropriate treatment 
was given to both groups for 12 weeks. The patient who are getting TCM treatment had 42 cases, and the SM group 
had 35 cases. Real-time quantitative fluorescent PCR detects interleukin 10 and interleukin 17 (IL-10 and IL17 
respectively) and matrix metal-oproteinase 9 commonly known as MMP-9 expression levels including monocyte 
blood transforming growth factor 1 (MBTGF-β1). A diagnosis of IL-10 or IL-17 or, MMP-9 as well as MBTGF- β1 
is monitored in peripheral blood which were treated before and after consecutively.  
Results: MBTGF-β1-RNA decreased among the SM group children after the treatment Whereas after treatment no 
major variances in MMP-9 among TCM and the SM children group were noted (0.05>0.05). The amount of IL-10 
including IL-17 and MMP-9 expressively declined (p = 0.01, 0.04 and 0.03 respectively) in the TCM group. On the 
other hand, MMP-9 and MBTGF- β1 levels expressively declined in the SM group following therapy. The IL-10 as 
well as IL-17, and MBTGF-β1 and MMP-9 values in the two groups were not significantly different (> 0.05). The 
differences between IL-17 and c-ACT scores in the Chinese medicine group and SM group were adversely 
correlated.  
Conclusions: Traditional Chinese Medicine has controlling consequence on secretions of childhood asthma 
inflammatory mediators and help in asthma management immune mechanism. [Ethiop. J. Health Dev. 2020; 
34(4):262-267] 
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Introduction 
Paediatric asthma is a significant public health problem. 
For centuries, TCM played a important part in treating 
the diseases not only within China but also in other 
countries in Asia, where it is usually used a 
monotherapy or combined medicine. TCM is one of the 
oldest health practices on earth.  
TCM has a specific theory, diagnosis and treatment (1), 
where the main modes of treatment are acupuncture and 
Chinese herbal medicines (CHMs). Nevertheless, the 
situation in China, the role of TCM as conventional 
medicine in the USA and other Western countries is 
relatively undeveloped. Even so, TCM and CHM 
therapies have been introduced in Western medical 
centers in the USA (2,3), and patients undergo TCM 
therapy provided primarily by licensed non-hospital-
based TCM practitioners. CHMs are considered 
nutritional supplements in compliance with US law. The 
Center for Supplementary and Alternative Medicine was 
founded by the National Institutes of Health (NIHC) in 
1997 which is a part of bigger nexus of traditional 
medicines (4,5).  
 
Chronic inflammation of the airways involves bronchial 
asthma. It is characterized by eosinophils’ participation 
cells. Asthma has recently increased incidence all 
around the world where mortality study showed its 
pathogenesis. (6-7). An important part of development 
also plays major impact on Asthma bronchial. TCM for 
treatment of asthma has good results outcome among 
children. TCM  applied in in children with asthma, 
treated under various conditions during the disease’s 
phases and symptoms whereas the mechanism is 
empirical(8).  
TCM has been used to treat airway disorders, including 
bronchial asthma, for many centuries. For a certain 
proportion of asthmatic patients, clinical findings by 
both modern doctors and Chinese doctors suggest a 
certain degree of efficacy (9). It is well known that 
ephedrine (C10H15NO), which is extensively used in 
asthma as a bronchodilator, acting as central nervous 
system stimulant, was extracted from Ma Huang 
(Ephedra sinica), and has been used for centuries in 
TCM to treat acute asthma (10). Ma Huang is commonly 
used in contemporary medicine for treating bronchial 
asthma now a days. In addition, some pure compounds, 
including antagonists in Platelet Activating Factor 
(PAF), with an anti-inflammatory effect, were isolated 
from herbs used in TCM, and used to treat bronchial 
asthma (11-13). It is important to examine the clinical 
effectiveness of TCM using empirical methods of 
modern medicine and to explore the mechanisms 
through which it functions.   
 
Materials and methods 
Invention project: The research consisted of a 
controlled, single-blind randomized study carried out at 
the University Affiliated Huangdao District Hospital, 
Qingdao City, Shandong Province, China. Standard 
treatments for children with asthma (salbutamol and 
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montelukast) were used as positive controls to determine 
the clinical effectiveness of TCM. Random numbering 
method was used and sample size were calculated 
according to the medication given to them in a random 
way. All the subjects who gave written consent and 
wanted to give veins were chosen. They were separated 
into two groups based on a random numbering method. 
Student's T-test were used as there were two groups in 
consideration. Usually the t-Test depending on the 
groups consists of either single population or multiple 




Where t is the t-value and X1 and X2 are the means of 
the two groups being compared. S2 is the pooled 
standard error of the two groups, and n1 and n2 are the 
number of observations in each of the groups. 
 
Criteria for selection: This research fulfils the 
investigative standards set in 2008, based on the Chinese 
Medical Association Paediatric Bronchial Asthma 
Standards for the Respiratory Group (14). Traditional 
Chinese health administration has defined TCM 
syndrome based on the ‘TCM syndrome diagnosis and 
clinical effectiveness criteria’ (15). The study consisted 
of children between 3 and 12 years old. Children were 
selected for inclusion in the present study, according to 
their severity of asthma diagnosis criteria. Asthma 
attacks are classified as the following according to 
Chinese medicine differentiation syndromes: a type of 
mucus-generated heat that prevents lung or cold liquid 
from staying in the lungs, lung and spleen diseases and 
renal failure. Patients with congenital, cardiovascular 
and cancer diseases were excluded. 
 
Subjects: 167 subjects with asthma were chosen and 
divided in SM children group (n=77) and TCM children 
group (traditional Chinese medicine) (n=90), on the 
basis of a random numbering method, between March 
2018 and December 2019. All the children have to sign 
a written consent (in case of minor by parents) to donate 
samples and then assigned the samples to various groups 
by chance. Fortyy-two TCM patients were treated 
before and 35 MS patients received venous blood 
treatment later on. In the TCM group, 28 were males and 
14 females, between age of 5.0±1.5 years and an average 
illness duration of 8.2±6.3 months. In the SM children 
group, 20 were males and 15 females. Their average age 
was 5±1.2 years and their average disease duration was 
7.6±6.5 months. In terms of age, gender and illness, 
there was no significant variance between the two 
groups. 
 
Interventions: In the TCM group, patients with acute 
asthma attacks were given a ‘Shegan’ mixture consisting 
of 9grams of ephedrine, 9 grams of almonds, 6 grams of 
China Bela Ganda of, 9 grams of Indian rib grass, 
9grams of yellow wedge from Chinese root tuber of the 
plant Pseudostellaria heterophylla and 9 grams of wild 
wedge from Chinese mountains commonly known as 
Cang Er Zi. Patients took 10ml of the blend three times 
a day for seven days. The medicine was accustomed 
slowly to the TCM group, and CS results during the 
four-week and eight-week follow-up period 
respectively.  
 
Patients in the TCM group with persistent asthma were 
given the Shegan mixture and ‘Astragalus kidney tonic’. 
The tonic combination was treated with 9 grams of 
astragalus, 9 grams of actylode, 15 grams of Chinese 
yam, 9 grams of Pseudostellaria heterophyll, 12 grams 
of coconut, and 9 grams of Indian medicinal mulberry. 
Astragalus kidney tonic enhances the immune system 
and reduces inflammation. It is also used as an 
antihistamine and to treat heart conditions, as well as 
disorders of the kidney. Additional herbs are added or 
removed depending on the symptoms. For example, for 
nasal congestion and sneezing, magnolia and dogwood 
are included; for hyperhidrosis, ephedrine and floating 
weed are added. The therapy lasted 12 weeks. Herbs 
used complied with Chinese Pharmacopoeia quality 
standards (2005) (16).  
 
Among the SM children, who has severe asthma treated 
first with bronchodilators, 2 to 4mg daily, for seven 
consecutive days. Leukotriene receptor and montelukast 
sodium were received by patients in clinical remission 
at a dose of 4-5mg per night for three months. 
Salbutamol and montelukast were given to patients with 
persistent asthma. Antibiotics or aerosol therapy were 
also directed in cases of severe bacterial contamination 
and breathless. 
 
Products: The amount of IL-10 and IL-17 including 
MMP-9 and MBTGF-β1 with marginal blood and 
mRNA countenance changed 12 weeks before and after 
treatment.  
 
C-ACT: The childhood Asthma Control Test (c-ACT) is 
an extensively used method of perceiving poorly 
controlled asthma in children. This c-ACT test 
comprises seven queries, separated into two portions: 
parents of the child were asked the first four questions. 
Based on the condition of the child, the doctor answers 
the remaining three questions. Scores from 23 to 27 are 
considered a good check for a total of 27 points. Partial 
control 20-22; and poor asthma control 0-19. Experts are 
strictly responsible for the quality of this test. Although 
in this research this C-ACT has not been applied but it 
is useful to add in this manuscript to let the audience 
understand and detect asthma in children. 
 
Collection and treatment of specimens: Samples from 
the peripheral blood (2ml) of children with asthma were 
collected and placed in an ethylenediaminetetraacetic 
acid (EDTA) anticoagulation tube. At 2,500 rpm for 15 
min, the plasma was removed and frozen for further 
analysis for 5 minutes. The Ficoll method were used for 
the separation of peripheral blood mononuclear cells 
(PBMCs). 
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Rt-PCR  
Total mRNA was also removed with the help of TRIzol 
RNA substance removal. The Primer Premier 5.0 (PRE-
Primer Sequence) and Amplicon Size are shown in 
Table 1 which is standard notation of DNA sequences 
from 5’ to 3’. Real-time quantifiable Reverse Transcript 
Polymerase Chain reaction (qRT-PCR) were conducted  
 
on the Mastercycler ep realplex Real-time PCR System 
(Eppendorf AG, Hamburg, Germany) by means of 
SYBR green premix Ex Taq. The process was as 
follows: initially denatured for 20 minutes at 95oC; 
desaturated for 30 seconds at 95oC, 30 seconds at 54-
55oC, then extended for 40 seconds at 44oC. The 
comparative quantity of the objective gene mRNA to 
GAPDH was normalized. 
 
Table 1: Primer sequence and amplicon dimensions  


















Enzyme-linked immunosorbent assay (ELISA) were 
done to understand the total circulating levels of PBMC 
to see they had a significant effect on the extrapolated 
values. The marker was associated with the provided kit 
prepared by RayBiotech, Inc. (Peachtree Corners, 
Georgia, USA). Centrifugation and sample 
anticoagulation were used to get the plasma. Use the 
double antibody kit for IL-17, MMP-9, IL-10, and 
MBTGF-β1measurement according to the instructions 
in the kit. The kit was provided by RayBiotech, Inc, 
USA, and the optical density (OD) value was detected at 
450nm using a microplate reader. The standard IL-17 
and IL-10 and MMP-9 and MBTGF-β1 dilution 
solutions were prepared.  
 
Statistical analysis 
In order to establish baseline equivalents and differences 
between the two groups, the demographic data were 
analysed. The continuous variables are expressed as 
average ± standard deviation (StdDev) and estimated by 
means of Student’s t-test, in accordance with the normal 
distribution. The misplaced data were evaluated using 
the t-test following the protocol conversion. The 
correlation analysis of the typically disseminated 
variables was analysed by means of Spearman’s 
correlation coefficient. Every statistic remained 
examined by means of SPSS software version 22. The 
statistically significant value of 0.05<0.05 is considered. 
T-test was employed.  
 
Results 
In all IL-17, MMP-9, IL-10, and MBTGF-β1 we 
compared expression levels of mRNA. Not all-
important changes in the TCM and SM groups 
(0.05>0.05) were observed after therapy (see Table 2) as 
they have various timeframe according to the individual 
body reaction given by Std-Dev. In case of SM children 
group of patients, the appearance of MBTGF-β1 mRNA 
declined. Subsequently treatment with TCM, there were 
no noteworthy alteration in IL-10, IL-17, MBTGF-
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Table 2: Evaluation of mRNA expressions of IL-17, MMP-9, IL-10, and MBTGF-β1in the children 
groups (mean ± standard deviation) 
Variables TCM group (n = 42) SM group (n = 35) 
 Before treatment After treatment p value Before treatment After treatment 
p 
value 
IL-17 5.1±7.9 7.9±7.3 0.41 4.1±6.5 8.5±10.9 0.21 
MBTGF-
β1 
195.4±93.9 169.9±84.0 0.51 226.5±129.5 121.2±61.2 0.01 
MMP-9 2.3±3.4 3.1±4.1 0.99 1.5±2.9 1.5±3.5 0.91 
IL-10 0.6±0.2 0.5±0.5 0.59 0.4±0.6 0.6±0.69 0.59 
 
Assessment of marginal blood levels of the IL-17, IL-10 
including MBTGF-β1 as well as MMP-9 were 
performed. But after treatment no major differences was 
observed in case of peripheral blood levels amongst the 
TCM children group and SM groups (treatment > 0.05) 
at IL-17, IL-10, MBTGF-β1 and MMP-9 levels. 
Following therapy, the TCM children group (decline = 
0.01, 0.04 and 0.03, respectively), levels of IL-17, IL-
10, and MMP-9 were expressively reduced. It was also 
observed the same trend in SM group children, after 
treatment, IL-17, MMP-9 and MBTGF-β1 levels (see 
Table 4) were significantly reduced. 
 
Table 3: Evaluation of peripheral blood of IL-17, MMP-9, IL-10, and MBTGF-β1in children groups 
(pg/mL, MMP-9ng/mL, mean ± SD) 
 
Variables Before treatment After treatment 
 
TCM group  
(n = 42) 
SM group  
(n = 35) 
p value 
TCM group  
(n = 42) 
SM group  
(n = 35) 
p value 
IL-17 1,910.8±1860.5 1,840.8±1550.5 0.99 1,070.5±685.7 920.2±445.3 0.55 
MBTGF-
β1 
999.5±905.1 1,510.2±990.8 0.03 1,075.3±725.1 630.6±392.5 0.05 
MMP-9 380.5±115.5 420.2±172.3 0.51 305.4±70.2 325.1±95.5 0.40 
IL-10 40.3±59.9 20.6±10.9 0.07 10.4±6.0 15.0±12.2 0.42 
 
After 12 weeks of treatment, the value of c-ACT in the 
TCM children group was significantly greater than the 
previous one (22.5±1.9, 16.5±1.9, compared with < 
0.001). In the SM group, after 12 weeks of treatment, the 
value of c-ACT significantly increased (after 22.1±2.0 
compared to p<0.001 before 17.0±2.2). The difference 
between IL-17 and the c-ACT scores in the TCM group 
including SM children was negatively related. 
Alteration in c-ACT scores in the two groups in relation 
to IL-10, MBTGF-β1 and MMP-9 levels (see Tables 5) 
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Table 4: Relationship between changes of c-ACT and t levels of IL-17, IL-10, MBTGF-𝛽1, and MMP-
9 in the TCM children’s group 
Variables d IL-10 d IL-17 d MMP-9 d ACT d MBTGF-𝛽1 
d IL-10 1.0000     
d IL-17 -0.9000 1.1000    
d MMP-9 -0.2000 -0.1000 1.0000   
d-ACT 0.8721 -0.9737 0.2052 1.0000  
d MBTGF-𝛽1 -0.6190 0.5010 -0.4100 -0.5642 1.0000 
 
Table 5: Relationship between changes of c-ACT and t levels of IL-17, IL-10, MBTGF-𝛽1, and MMP-
9 in the SM children 
Variables d IL-10 d IL-17 d MMP-9 d ACT d MBTGF-𝛽1 
d IL-10 1.0000     
d IL-17 0.1120 1.0000    
d MMP-9 0.4762 0.0238 1.0000   
d ACT -0.4514 -0.7123 -0.2629 1.0000  
d MBTGF-𝛽1 0.4049 0.0080 -0.2391 -0.1529 1.0000 
 
Discussion 
Asthma is a chronic inflammatory disorder that plays an 
important role in several cells and cytokines. We have 
adopted Chinese herbal formula for step therapy to 
inflammatory mediators and released cytokines, which 
deals with asthma attacks. Earlier studies show that 
asthma patients can be linked with Th1/Th2 imbalance 
by the pathogenesis of inflammation by the airway. The 
increase in Th2 cell number (IL-5, IL-4, and IL-10), 
which is a major element in the induction and 
maintenance of cellular inflames, leading to increased 
secretion of Th2 cells (17-18). In previous studies, we 
found many empirical prescriptions to regulate 
leukotriene and immune cell imbalances in asthma 
attacks on the expression of leukotriene receptors and 
observed the empirical prescriptions for treatment for 
asthma attacks in TCM (7,19). The most prevalent two 
types of receptor are CysLT1 and CysLT2. As we know 
CysLT1 receptor is generally expressed in annoyance, 
lung muscle cells and interstitials lungs macrophage 
blood leukocyte and eosinophils. Whereas the receptor 
CysLT2 is mostly found in placenta, heart, and in 
leukocytes of peripheral blood. It can efficiently control 
and enhance different lung function indicators (8).  
 
In this study, we examined several additional asthma-
related cytokines, including IL-17, IL-10, MBTGF-β1 
and in MMP-9, for purpose in clarifying the immune 
mechanisms for TCM treatment for asthma. Previous 
studies showed that Shegan’s mixture and ephedrine are 
extracted in TCM formulas. One specific medicine 
cannot reduce asthma. They are present in various forms 
and nomenclatures Early studies have shown that the 
belamcandae and the ephedrine can also help recovering 
patients’ immune systems (preventing hypersensitivity 
responses efficiently) (19), reducing  the severity of 
childhood asthmatic cough, and altering IL-10 serum 
levels.  
 
IL-13 and IL-14:  
Luo et al. (20) found MBTGF-β1 in the belamcandae 
and ephedrine decoction group to be reduced compared 
to the asthma model group of children studied, bronchial 
wall thickness and smooth muscle thickness was 
reduced, and inflammatory cell infiltration decreased. 
The IL-10 level reduced 12 weeks of therapy afterward 
with TCM, indicating that the secretion of IL-10 to 
control asthma attacks could reduce TCM, thereby 
inhibiting inflammation of the respiratory system. We 
found no difference in the serum concentration of 
MBTGF-β1 after 12 weeks of TCM therapy. The 
various result obtained in this experimental test as well 
as in different studies can be accredited to the various 
methods employed to enumerate inflammatory 
mediators’ secretion stages. 
 
Current studies show that asthma is also associated with 
Th17/Treg imbalances. In airway restructuring and 
inflammation by chemotaxis and neutrophil activation, 
IL-17 plays an important role (16). MMP-9 is also 
involved in the remodelling of airways through the 
destruction of collagen and promoting the migration of 
epithelium (21). Miao et al. (14) conclude that ‘Zhike 
Pingchuan Mixture could reduce IL-17 and MMP-9 
expression in lung tissues and progress asthma airway 
remodelling. In the empirical prescription of TCM, our 
study decreased peripheral blood levels of IL-17 and 
MMP-9 and indicated a controlling consequence on IL-
17 and MMP secretion. C-ACT results were also 
recorded to assess the control of asthma. The results 
showed that after 12 weeks of TCM treatment, the c-
ACT levels increased at a similar rate to our earlier 
studies (17-19). Liu et al. found (22), and this was 
confirmed by our research, that the results of c-ACT 
could well reflect clinical symptoms. The results also 
demonstrate that differences between IL-17 and change 
in c-ACT in the TCM group were negatively correlated. 
We assume that Chinese medicine has been proven to 
reduce IL-17 secretion, inhibiting the inflammation of 
the airways. Of particular interest, there has been no 
variation in Chinese treatment group IL-17, IL-10, and 
the MMP-.9 mRNA, and with all of these the serum 
levels have been reduced among all children. These 
results were not in line with our expectations.  
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Conclusions 
Chinese medicine empirically prescribed may affect 
cytokine levels in the translation process. In this study 
we demonstrated that the TCM can efficiently regulate 
asthma occurrences and decrease peripheral blood 
amount of MMP--9, IL--10, IL--17 (23). TCM has been 
verified to have a controlling consequence on the 
secretions of certain childhood asthma inflammatory 
mediators and can help comprehend asthma 
management immune mechanisms. 
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